Changes in Hong Kong stocks | Rongchang Biotech (09995) rose more than 4% and plans to buy back the company's A shares for 30 million yuan to 60 million yuan

The Zhitong Finance App learned that Rongchang Biotech (09995) rose by more than 4%. As of press release, it had risen 4.64% to HK$65.45, with a turnover of HK$30.645,500.

According to the news, on November 2, Rongchang Biotech issued an announcement. The company's board of directors deliberated and passed the “Proposal on the 2026 Second Plan to Repurchase the Company's Shares through Centralized Bidding Transactions”, which intends to use the company's own funds and/or self-raised funds to repurchase the company's A shares through centralized bidding. The repurchased shares are used to protect the company's value and shareholders' rights. The share repurchase amount is not less than 30 million yuan (inclusive), no more than 60 million yuan (inclusive), and the share repurchase price is not more than 131 yuan/share (inclusive).

In addition, Rongchang Biotech announced that as of October 31, 2026, the company had repurchased 60,000 shares of the company through centralized bidding transactions through the Shanghai Stock Exchange trading system, accounting for 0.0106% of the company's total share capital. The highest price of the repurchase transaction was 113.7 yuan/share, the lowest price was 108.30 yuan/share, and the total amount of capital paid was RMB 6.632 million (not including transaction fees such as transaction commissions).